Home> Products> amisulpride therapy for resistant depression

{ "products": [ { "_id": "68b02b8ff27bc023db27903e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DULOXTIME 60", "description": "DULOXTIME 60 contains Duloxetine 60 mg, designed in gastro-resistant tablet form to ensure smooth absorption in the intestine while reducing stomach irritation. Duloxetine is classified under serotonin and norepinephrine reuptake inhibitors (SNRIs), a group of medicines that help balance key brain chemicals—serotonin and norepinephrine. These neurotransmitters play a crucial role in regulating mood, emotional stability, pain perception, and nerve signaling.\n\nUses of DULOXTIME 60\n\nDULOXTIME 60 is a multipurpose therapy widely prescribed for both mental health conditions and pain-related disorders:\n\nMajor Depressive Disorder (MDD): Elevates mood, restores energy, and enhances quality of life in patients with depression.\n\nGeneralized Anxiety Disorder (GAD): Helps reduce constant worry, nervousness, and related physical symptoms such as restlessness and palpitations.\n\nDiabetic Peripheral Neuropathy: Relieves nerve pain, burning, and tingling sensations linked to diabetes.\n\nFibromyalgia: Eases widespread musculoskeletal pain and fatigue associated with fibromyalgia.\n\nChronic Musculoskeletal Pain: Effective for long-term pain conditions such as chronic back pain and osteoarthritis.\n\nSide Effects of DULOXTIME 60\n\nThough well-tolerated by most, some individuals may experience side effects:\n\nCommon Side Effects:\n\nNausea or constipation\n\nDry mouth\n\nDizziness, fatigue, or sleepiness\n\nIncreased sweating\n\nReduced appetite\n\nLess Common but Serious Side Effects:\n\nSevere mood changes or suicidal thoughts (particularly in younger patients)\n\nLiver problems (jaundice, abdominal pain, dark urine)\n\nRapid heartbeat or high blood pressure\n\nAllergic reactions such as swelling, rash, or itching\n\nSeek immediate medical help if severe side effects occur.\n\nPrecautions Before Taking DULOXTIME 60\n\nMental Health Monitoring: Patients with depression or anxiety should be closely observed for any worsening of symptoms or suicidal tendencies.\n\nLiver and Kidney Disorders: Should be avoided in those with severe liver or kidney disease.\n\nBlood Pressure & Heart: Regular monitoring is recommended as Duloxetine may raise blood pressure or alter heart rate.\n\nAlcohol Consumption: Avoid alcohol to reduce the risk of liver damage.\n\nPregnancy & Breastfeeding: Use only if prescribed by a doctor.\n\nDriving & Alertness: May cause dizziness or sleepiness; avoid driving or heavy machinery until you know how it affects you.\n\nDrug Interactions of DULOXTIME 60\n\nOther Antidepressants (SSRIs, MAOIs): May cause serotonin syndrome, a potentially serious condition.\n\nPainkillers (NSAIDs, Aspirin, Blood Thinners): Higher risk of bleeding.\n\nAlcohol or Liver-Toxic Drugs: Can increase chances of liver injury.\n\nStimulants: May worsen anxiety or palpitations.\n\nCertain Antibiotics/Antifungals: Can alter Duloxetine levels in the body.\n\nConclusion\n\nDULOXTIME 60 (Duloxetine Gastro-Resistant Tablets IP 60 mg) is a well-established and trusted option for managing depression, anxiety, nerve pain, fibromyalgia, and chronic musculoskeletal pain. By stabilizing brain chemicals and reducing pain signals, it not only improves emotional health but also provides physical relief, ensuring a better overall quality of life for patients.", "price": 368.0, "discountamount": 110.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2169, "imageuri": "https://productimages.withfloats.com/actual/68b02b92c670a5043ed545f2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b02b92c670a5043ed545f2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T10:12:31.244Z", "updatedon": "2025-08-28T10:22:44.825Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/duloxtime-60/2169", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Duloxetine 60 mg Tablet", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ac8a1ca84cd189c25c6ce", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OLANZPRIME FOX 5/20 ", "description": "OLANZPRIME FOX 5/20 \nFluoxetine (20mg) & Olanzapine (5mg)\nIntroduction:\n\nOLANZPRIME FOX 5/20 is a combination medication containing Fluoxetine (20 mg) and Olanzapine (5 mg), designed to treat depressive episodes associated with bipolar disorder and treatment-resistant depression. This combination harnesses the antidepressant effects of Fluoxetine and the antipsychotic properties of Olanzapine to provide comprehensive management of these complex conditions.\n\n\nOLANZPRIME FOX 5/20: Effective Combination Therapy for Depression and Bipolar Disorder\n\nFluoxetine (20 mg) & Olanzapine (5 mg)\n\nIntroduction:\n\nOLANZPRIME FOX 5/20 is a combination medication containing Fluoxetine (20 mg) and Olanzapine (5 mg), designed to treat depressive episodes associated with bipolar disorder and treatment-resistant depression. This combination harnesses the antidepressant effects of Fluoxetine and the antipsychotic properties of Olanzapine to provide comprehensive management of these complex conditions.\n\nKey Features and Benefits:\n\nDual Action: The combination of Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), and Olanzapine, an atypical antipsychotic, targets both mood stabilization and depression, providing a synergistic effect.\nDepression Treatment: Fluoxetine effectively treats major depressive episodes by increasing serotonin levels in the brain, improving mood, and alleviating depressive symptoms.\nBipolar Disorder Management: Olanzapine helps manage manic and mixed episodes associated with bipolar disorder, reducing symptoms such as mood swings, agitation, and irritability.\nComprehensive Symptom Relief: The combination addresses a broad spectrum of symptoms, including anxiety, agitation, and cognitive disturbances, offering holistic treatment for patients with complex mental health needs.\nProven Efficacy: The combined therapy of Fluoxetine and Olanzapine is well-established, with clinical evidence supporting its effectiveness in treating bipolar depression and treatment-resistant depression.Dosage and Administration:\n\nInitial Dosage: The typical starting dose of OLANZPRIME FOX 5/20 is one tablet taken once daily, usually in the evening due to Olanzapine’s sedative effects.\nMaintenance Dosage: The dosage may be adjusted by a healthcare provider based on the patient's response to treatment and the severity of symptoms. Regular follow-ups are necessary to monitor effectiveness and adjust the dosage accordingly.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take OLANZPRIME FOX 5/20 at the same time each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/olanzprime-fox-5-20-134396", "price": 60.0, "discountamount": 10.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SSRI", "food", "EMAIL", "brain", "manic", "water", "product", "anxiety", "evening", "Benefits", "patients", "severity", "response", "same time", "agitation", "Fluoxetine", "Olanzapine", "one tablet", "mood swings", "information", "Dual Action", "bloodstream", "sterisonline", "sterispharma", "irritability", "Introduction", "Key Features", "effectiveness", "CALL/WHATSAPP", "Initial Dosage", "broad spectrum", "Administration", "OLANZPRIME FOX", "mixed episodes", "Proven Efficacy", "sedative effects", "serotonin levels", "combined therapy", "clinical evidence", "mood stabilization", "Maintenance Dosage", "holistic treatment", "bipolar depression", "Regular follow-ups", "synergistic effect", "complex conditions", "depressive symptoms", "healthcare provider", "Depression Treatment", "typical starting dose", "combination medication", "cognitive disturbances", "atypical antipsychotic", "antidepressant effects", "antipsychotic properties", "comprehensive management", "major depressive episodes", "Bipolar Disorder Management", "complex mental health needs", "consistent medication levels", "Comprehensive Symptom Relief", "Effective Combination Therapy", "treatment-resistant depression", "selective serotonin reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1866, "imageuri": "https://productimages.withfloats.com/actual/667d224c1657b0caada54cc6.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d224c1657b0caada54cc6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:23:29.686Z", "updatedon": "2024-06-27T08:26:51.772Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/olanzprime-fox-5-20-/1866", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME FOX 5/20 ", "category": "NEUROLOGY RANGE", "tags": [ "olanzprime fox 5/20 mg price", "olanzprime fox 5/20 mg", "olanzapine 5 mg fluoxetine 20 mg", "olanzapine side effects long-term" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68723260f860f0528a938842", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AMIPULSIDE CR 400", "description": "AMIPULSIDE CR 400 is a prescription-based, controlled-release formulation of Amisulpride 400 mg, developed to offer sustained therapeutic effects with once-daily dosing. Manufactured to high quality standards, this medication plays a vital role in the management of both acute and chronic schizophrenic disorders. It belongs to the class of atypical antipsychotics and works by regulating the activity of certain neurotransmitters in the brain, primarily dopamine. This helps control symptoms like hallucinations, delusions, disorganized thinking, and social withdrawal associated with schizophrenia.\n\nWhat is AMIPULSIDE CR 400?\nAMIPULSIDE CR 400 contains Amisulpride, a selective dopamine D2/D3 receptor antagonist. It is primarily used in the treatment of schizophrenia, particularly effective in managing both positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., emotional withdrawal, apathy). The controlled-release (CR) formulation allows for steady absorption and action, improving patient compliance and reducing fluctuations in symptom control.\n\nThis medication is designed for the treatment of acute and chronic schizophrenic disorders and is often used as part of a comprehensive psychiatric care plan, including counseling and behavioral therapy.\n\nUses of AMIPULSIDE CR 400\nManagement of acute episodes of schizophrenia\n\nLong-term maintenance therapy for chronic schizophrenic disorders\n\nEffective in treating positive symptoms (e.g., hallucinations, paranoia)\n\nBeneficial in alleviating negative symptoms (e.g., lack of motivation, social withdrawal)\n\nSide Effects of AMIPULSIDE CR 400\nLike all medications, AMIPULSIDE CR 400 may cause side effects in some patients. Common side effects include:\n\nInsomnia or drowsiness\n\nWeight gain\n\nConstipation\n\nAnxiety\n\nIncreased prolactin levels (can lead to breast tenderness or menstrual changes)\n\nTremors or stiffness (extrapyramidal symptoms)\n\nSerious but rare side effects may include:\n\nNeuroleptic malignant syndrome (fever, muscle rigidity, confusion)\n\nIrregular heart rhythms\n\nSeizures\n\nSeek immediate medical help if you experience chest pain, severe dizziness, or signs of an allergic reaction.\n\nPrecautions Before Using AMIPULSIDE CR 400\nBefore starting treatment with AMIPULSIDE CR 400, inform your doctor if:\n\nYou have a history of heart disease or irregular heart rhythms\n\nYou suffer from kidney or liver dysfunction\n\nYou are pregnant, planning pregnancy, or breastfeeding\n\nYou have Parkinson’s disease\n\nYou have low potassium or magnesium levels in your blood\n\nAvoid alcohol and other central nervous system depressants while taking this medication, as they may increase drowsiness or impair alertness.\n\nDrug Interactions\nAmisulpride can interact with a variety of medications, which may enhance or diminish its therapeutic effects or increase the risk of adverse events.\n\nWhat Drugs Interact with AMIPULSIDE CR 400?\nAntiarrhythmic drugs (e.g., quinidine, amiodarone): May increase the risk of heart rhythm abnormalities\n\nCNS depressants (e.g., benzodiazepines, opioids): Increase sedation and respiratory depression risk\n\nLevodopa and dopamine agonists: Can counteract the effect of Amisulpride\n\nSSRIs (e.g., fluoxetine, paroxetine): May increase the plasma levels of Amisulpride\n\nDrugs that prolong QT interval (e.g., erythromycin, haloperidol): May raise the risk of cardiac arrhythmias\n\nDiuretics: May alter electrolyte balance, increasing risk of heart rhythm disturbances\n\nAlways disclose all medications, supplements, or herbal products you are taking to your healthcare provider before starting AMIPULSIDE CR 400.\n\nConclusion\n\nAMIPULSIDE CR 400 (Amisulpride 400 mg CR Tablet) is a clinically effective medication for individuals suffering from schizophrenia, offering reliable symptom control through its controlled-release formulation. Its ability to treat both the acute and chronic phases of the disorder makes it a cornerstone in psychiatric management. Regular monitoring and adherence to prescribed guidelines ensure optimal results and improved quality of life for patients.", "price": 595.0, "discountamount": 179.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2145, "imageuri": "https://productimages.withfloats.com/actual/687232764d22e47aa874e361.png", "tileimageuri": "https://productimages.withfloats.com/tile/687232764d22e47aa874e361.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-12T10:01:04.938Z", "updatedon": "2025-07-12T10:01:04.938Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/amipulside-cr-400/2145", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "amisulpride tablet", "category": "NEUROLOGY RANGE", "tags": [ "Amisulpride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35d815432f8f0afe662b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg", "description": "GLIEMPAFLOZIN MET ER is a combination medication used to manage type 2 diabetes mellitus (T2DM) by helping control blood sugar levels effectively. It contains two powerful anti-diabetic agents, Empagliflozin and Metformin Hydrochloride (Extended Release), which work together to enhance glucose regulation and reduce the risk of diabetes-related complications. This medication is recommended for patients who require additional glycemic control beyond lifestyle changes and monotherapy treatments.\n\n \nKey Benefits\n \n\n Effective Blood Sugar Control – Helps reduce and maintain optimal blood glucose levels in type 2 diabetic patients.\nWeight Management – Empagliflozin promotes caloric loss through urinary glucose excretion, potentially aiding in weight reduction.\nReduced Risk of Cardiovascular Diseases – Beneficial for heart health, lowering the risk of cardiac complications in diabetic patients.\nInsulin Sensitivity Improvement – Metformin enhances insulin function, reducing insulin resistance.\nLower Risk of Hypoglycemia – A balanced mechanism of action ensures stable blood glucose levels without sudden drops.\nKidney Protection – Empagliflozin may help protect against diabetic nephropathy by reducing kidney stress.\nExtended-Release Formula – Ensures long-lasting blood sugar control with a once-daily dosage for improved patient compliance.\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine, thereby reducing blood sugar levels.\nMetformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, enhances insulin response, and delays glucose absorption in the digestive tract.\nTogether, they provide a dual action approach for better glycemic control while minimizing side effects like hypoglycemia.\n \nDirections for Use\n \n\nDosage: Take one tablet per day, preferably with food or as directed by your healthcare provider.\nSwallow whole with a glass of water; do not crush or chew.\n Maintain a healthy diet and follow a regular exercise routine for optimal results.\nRegular monitoring of blood sugar levels is advised.\nDo not stop taking this medication without consulting your doctor.\n\n \nSide Effects:\n \n\nSome individuals may experience mild to moderate side effects, including:\n\nFrequent urination (due to glucose excretion)\nDehydration (increased fluid loss)\nNausea, vomiting, or stomach upset\nDiarrhea or constipation\nMetallic taste in the mouth\nLow blood pressure (Hypotension)\nVitamin B12 deficiency (with long-term use of Metformin)\nUrinary tract infections (UTIs) or genital infections\n Seek medical attention if you experience severe allergic reactions, extreme dizziness, or difficulty breathing.", "price": 245.0, "discountamount": 74.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "combination medication", "hypoglycemia directions", "oncedaily dosage", "difficulty breathing", "experience mild", "stop taking", "healthy diet", "chew maintain", "day preferably", "glycemic control", "digestive tract", "sglt2 protein", "diabetic nephropathy", "balanced mechanism", "cardiac complications", "diabetesrelated complications", "constipation metallic taste", "stomach upset diarrhea", "frequent urination due", "moderate side effects", "doctor side effects", "blood sugar levels", "regular exercise routine", "healthcare provider swallow", "minimizing side effects", "dual action approach", "delays glucose absorption", "improved patient compliance", "heart health lowering", "cardiovascular diseases beneficial", "enhance glucose regulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2049, "imageuri": "https://productimages.withfloats.com/actual/67a35d9d1b599c6f20ba1fa7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35d9d1b599c6f20ba1fa7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:45:53.712Z", "updatedon": "2025-03-27T09:45:21.627Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25mg-metformin-hydrochloride-extended-release-1000-mg/2049", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET ER ", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin + metformin brand name in india", "empagliflozin + metformin combination brand name", "empagliflozin 12.5 mg+metformin 500 mg price", "Empagliflozin and metformin hydrochloride extended-release tablets", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35ad2c50c07ee3dcaceda", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg", "description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "lower risk", "nephrons reduces", "reducing strain", "weight management", "diabetes management", "chest pain", "doctor immediately", "lactic acidosis", "rare cases", "prolonged metformin", "nausea diarrhea", "experience mild", "crush chew", "glycemic control", "mechanisms ensure", "peripheral tissues", "kidneys leading", "diabetes treatments", "hypoglycemia unlike", "bodys response", "heart disease", "weight loss", "medication aids", "regular exercise", "proper diet", "biguanide therapy", "sglt2 inhibition", "complementary mechanisms", "empagliflozin dehydration", "excess glucose", "eliminating excess glucose", "work empagliflozin works", "diabetic ketoacidosis consult", "frequent urination due", "moderate side effects", "gliempaflozin met 125mg1000mg", "results side effects", "healthcare provider timing", "insulin production directions", "enhances insulin sensitivity" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2047, "imageuri": "https://productimages.withfloats.com/actual/67a35b5ff147b76947dad0ce.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35b5ff147b76947dad0ce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:34:26.615Z", "updatedon": "2025-03-22T10:19:44.132Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-1000mg/2047", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ", "category": "", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122bef263d0316fb4c9dcb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gliclazide IP (40 mg) , Pioglitazone Hydrochloride IP (15 mg) , Metformin Hydrochloride IP (500 mg)", "description": "TRI-GLICLAGLAZE 40 is a powerful oral anti-diabetic medication formulated to manage Type 2 Diabetes Mellitus effectively. This combination of three potent drugs—Gliclazide, Pioglitazone, and Metformin—works synergistically to control high blood sugar levels, improve insulin sensitivity, and help patients achieve better glycemic control. TRI-GLICLAGLAZE 40 is designed for patients who struggle to manage blood glucose levels with single medications or lifestyle changes alone. It is a comprehensive solution for long-term diabetes management and reducing the risk of complications related to uncontrolled blood sugar.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: TRI-GLICLAGLAZE 40 helps maintain optimal blood glucose levels by targeting different aspects of diabetes management, such as stimulating insulin release, improving insulin sensitivity, and reducing glucose production.\nReduces Insulin Resistance: Pioglitazone and Metformin work together to lower insulin resistance, making it easier for the body to use insulin effectively.\nImproves Long-Term Glycemic Control: By combining three active ingredients, this medication is particularly beneficial for those struggling with glycemic control through diet or monotherapy alone.\nReduces Risk of Diabetes Complications: Controlling blood sugar levels helps prevent diabetes-related complications such as nerve damage, kidney disease, and cardiovascular problems.\nSupports Weight Management: Metformin, in particular, has been known to assist with weight management, which is important for patients with Type 2 Diabetes.\n \n\nHow Does It Work?\n \nTRI-GLICLAGLAZE 40 works through a multi-faceted mechanism to lower blood glucose levels:\n\nGliclazide stimulates the beta cells in the pancreas to release more insulin, which lowers blood sugar levels post-meal.\n\nPioglitazone enhances the body's sensitivity to insulin by promoting glucose uptake in the muscle and fat cells while also decreasing glucose production in the liver.\n\nMetformin reduces the production of glucose in the liver and improves insulin sensitivity. It also decreases the absorption of sugar from the intestines, ensuring better blood sugar control throughout the day.\n\nThis combination of ingredients targets multiple pathways involved in glucose regulation, making it an effective option for individuals with Type 2 Diabetes who require more comprehensive blood sugar control.\n\n \n\nDirections for Use:\n \nTake TRI-GLICLAGLAZE 40 exactly as prescribed by your doctor.\nUsually, it is taken once or twice daily with meals to minimize gastrointestinal discomfort.\nSwallow the tablet whole with water—do not crush or chew the tablet.\nContinue following your diet and exercise plan alongside the medication to achieve optimal blood sugar control.\nDo not skip doses, and consult your healthcare provider if you miss a dose.\n \n\nSide Effects:\n \nLike any medication, TRI-GLICLAGLAZE 40 may cause side effects, although not everyone experiences them. Some common and mild side effects include:\n\nHypoglycemia (Low Blood Sugar): Due to Gliclazide’s insulin-stimulating properties, low blood sugar may occur, especially if meals are skipped or exercise is excessive.\n\nGastrointestinal Issues: Metformin is known to cause digestive problems in some individuals, including nausea, vomiting, diarrhea, or stomach cramps.\n\nWeight Gain: Pioglitazone may cause weight gain in some users due to increased fat storage.\n\nFluid Retention: Pioglitazone may lead to water retention, especially in patients with heart conditions, increasing the risk of heart failure.\n\nHeadache and dizziness: These may occur as the body adjusts to the medication, but they are generally mild and temporary.\n\nLactic Acidosis (rare): A serious but rare side effect of Metformin, this condition requires immediate medical attention and is characterized by muscle pain, breathing difficulties, and weakness.\n\n ", "price": 145.0, "discountamount": 43.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "fat cells", "beta cells", "muscle pain", "fat storage", "Weight Gain", "nerve damage", "Key Benefits", "exercise plan", "Gliclazide IP", "heart failure", "stomach cramps", "kidney disease", "glucose uptake", "water retention", "insulin release", "Lactic Acidosis", "Fluid Retention", "Low Blood Sugar", "heart conditions", "rare side effect", "multiple pathways", "different aspects", "lifestyle changes", "Weight Management", "mild side effects", "Insulin Resistance", "digestive problems", "single medications", "glucose production", "glucose regulation", "three potent drugs", "insulin sensitivity", "healthcare provider", "breathing difficulties", "Diabetes Complications", "comprehensive solution", "Metformin Hydrochloride", "Gastrointestinal Issues", "multi-faceted mechanism", "cardiovascular problems", "high blood sugar levels", "Type 2 Diabetes Mellitus", "three active ingredients", "uncontrolled blood sugar", "Long-Term Glycemic Control", "gastrointestinal discomfort", "immediate medical attention", "optimal blood sugar control", "optimal blood glucose levels", "Pioglitazone Hydrochloride IP", "long-term diabetes management", "Effective Blood Sugar Control", "diabetes-related complications", "insulin-stimulating properties", "comprehensive blood sugar control", "powerful oral anti-diabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1994, "imageuri": "https://productimages.withfloats.com/actual/67122bf4ac30f07ce03345d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122bf4ac30f07ce03345d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:35:43.008Z", "updatedon": "2024-10-18T09:35:43.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-ip-40-mg-pioglitazone-hydrochloride-ip-15-mg-metformin-hydrochloride-ip-500-mg-/1994", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRI - GLICLAGLAZE 40 ", "category": "DIABETIC RANGE", "tags": [ "gliclazide+metformin hydrochloride tablets uses", "Gliclazide Metformin Pioglitazone brand name", "Gliclazide and Metformin hydrochloride tablets Use", "Gliclazide and Metformin Hydrochloride tablets pri", "Gliclazide and Metformin Hydrochloride Tablets bra", "Gliclazide 80 mg and Metformin Hydrochloride table", "", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6ac7a81222f3e95890cfd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Efavirenz IP (600mg)", "description": "Efenavirez 600\nEfavirenz IP (600mg)\nEfenavirez 600 is a potent antiretroviral medication designed to combat HIV-1 infection effectively. The primary ingredient, Efavirenz IP (600mg), belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and is commonly used as part of combination therapy for the treatment of HIV/AIDS. Efenavirez 600 helps reduce the viral load in the body, improving immune function and preventing the progression of the disease.\n\n \n\nKey Benefits:\n \n\nEffective HIV-1 Treatment: Efenavirez 600 is highly effective in lowering the viral load in patients with HIV-1, improving their overall immune response.\nOnce-Daily Dosing: With a convenient once-daily dose, Efenavirez 600 simplifies the treatment regimen, promoting better adherence to therapy.\nPart of Combination Therapy: This medication is typically used alongside other antiretrovirals to provide a comprehensive approach to HIV treatment, reducing the risk of drug resistance.\n \n\nHow Does It Work?\n \n\nEfavirenz in Efenavirez 600 works by inhibiting the action of the reverse transcriptase enzyme, which is crucial for the replication of HIV-1. By binding to this enzyme, Efavirenz prevents the virus from converting its RNA into DNA, a necessary step for the virus to multiply within the host's cells. This inhibition reduces the overall viral load in the body, allowing the immune system to function more effectively and slowing the progression of the disease.\n\n \n\nDirections for Use:\n \n\nDosage: Efenavirez 600 is typically taken as one tablet daily, preferably at bedtime, to reduce potential side effects such as dizziness or drowsiness.\nAdministration: It is recommended to take this medication on an empty stomach or as directed by your healthcare provider. Ensure consistent use for maximum efficacy.\nMissed Dose: If a dose is missed, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and resume your regular schedule. Do not double the dose.\n \n\nSide Effects:\n \n\nCommon Side Effects: Dizziness, drowsiness, trouble sleeping, and vivid dreams may occur as your body adjusts to the medication. These effects are usually mild and diminish over time.\nSerious Side Effects: Rarely, Efavirenz can cause severe mental/mood changes (such as depression, suicidal thoughts), liver problems, or severe allergic reactions. Contact your healthcare provider immediately if you experience any unusual symptoms or worsening side effects.\nPrecautions: Inform your healthcare provider of any pre-existing conditions, particularly mental health issues or liver problems, as Efavirenz may exacerbate these conditions.", "price": 1825.0, "discountamount": 547.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "next dose", "daily dose", "Efavirenz IP", "vivid dreams", "Key Benefits", "empty stomach", "HIV treatment", "immune system", "consistent use", "liver problems", "necessary step", "HIV-1 infection", "drug resistance", "immune function", "unusual symptoms", "trouble sleeping", "regular schedule", "maximum efficacy", "one tablet daily", "suicidal thoughts", "treatment regimen", "primary ingredient", "overall viral load", "combination therapy", "healthcare provider", "Common Side Effects", "Serious Side Effects", "mental health issues", "other antiretrovirals", "comprehensive approach", "worsening side effects", "potential side effects", "pre-existing conditions", "overall immune response", "Effective HIV-1 Treatment", "severe allergic reactions", "severe mental/mood changes", "reverse transcriptase enzyme", "potent antiretroviral medication", "non-nucleoside reverse transcriptase inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1944, "imageuri": "https://productimages.withfloats.com/actual/66d6acd8550f4b1ce97e94bc.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d6acd8550f4b1ce97e94bc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T06:28:10.781Z", "updatedon": "2024-09-03T06:28:10.781Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/efavirenz-ip-600mg-/1944", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Efenavirez 600", "category": "GENERAL RANGE", "tags": [ "efavirenz 600 mg tablet", "efavirenz 600 mg uses", "efavirenz 600 mg side effects", "efavirenz 600 mg uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }